Skip to content

PEN

Penumbra, Inc.

NYSE · Healthcare · Medical - Devices · US

$322.17
+0.32%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue1.5B1.4B1.2B1.1B847.1M
Cost of Revenue484.0M461.2M439.6M375.9M311.9M
Gross Profit1.0B942.4M755.0M682.6M535.2M
Operating Expenses
R&D Expense92.2M89.8M94.8M84.4M79.4M
SG&A Expense741.3M663.4M574.0M506.5M449.7M
General & Admin Expense
Selling & Marketing Expense
Other Expenses18.2M
Total Operating Expenses833.6M753.2M668.8M609.1M529.1M
Cost and Expenses1.3B1.2B1.1B985.0M841.1M
Operating Income (EBIT)187.3M189.2M86.2M73.6M6.1M
Non-Operating
Interest Income19.7M16.3M13.7M6.8M1.9M
Interest Expense1.3M1.3M1.4M1.7M1.7M
Net Interest Income18.4M15.0M12.3M5.1M137.0K
Other Non-Op Income/Expense16.5M15.9M(65.4M)6.1M(2.2M)
Non-Operating Income (excl Interest)(17.8M)(17.2M)63.9M(7.8M)441.0K
EBT (Pre-Tax Income)203.8M205.1M20.9M79.7M3.9M
Income Tax Expense43.2M27.4M6.9M(11.3M)5.9M
Bottom Line
Net Income160.6M177.7M14.0M91.0M(2.0M)
Earnings from Cont. Ops160.6M177.7M14.0M91.0M(2.0M)
Earnings from Discont. Ops
Bottom Line Net Income160.6M177.7M14.0M91.0M(2.0M)
Per Share
Basic EPS$4.09$4.57$0.36$2.37($0.05)
Diluted EPS$4.07$4.52$0.36$2.32($0.05)
Revenue Per Share$38.28$36.07$30.92$27.56$22.39
Shares
Basic Shares Outstanding39.3M38.9M38.6M38.4M37.8M
Diluted Shares Outstanding39.6M39.3M39.3M39.2M37.8M
Profitability Metrics
EBITDA222.3M223.9M46.0M108.6M30.0M
D&A17.1M17.5M23.7M27.3M24.3M
EBIT205.1M206.4M22.3M81.4M5.6M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026